Trial Profile

CSP 571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary)
Indications Coronary artery disease; Coronary artery restenosis
Focus Therapeutic Use
Acronyms DIVA

Most Recent Events

01 Nov 2021 Results published in the American Journal of Cardiology
25 Aug 2017 The study follow-up ended on December 31, 2016.
25 Aug 2017 Trial enrollment was terminated on December 31, 2015 due to slower enrollment than expected and funding considerations.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com